NCT00006518
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +35 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Primary Effusion Lymphoma
Explore clinical trials studying Primary Effusion Lymphoma. Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
Primary Effusion Lymphoma trial results
Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
NCT05544019
- Conditions
- ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
- Locations
-
- Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States
- Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States
- Napa Research Pompano Beach, Florida, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Not Yet Recruiting
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
NCT07649304
- Conditions
- AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, +18 more
- Locations
-
Not specified
NCT01193842
- Conditions
- AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma, +39 more
- Locations
-
- Jackson Hospital and Clinic Montgomery, Alabama, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- UCLA Center for Clinical AIDS Research and Education Los Angeles, California, United States
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Completed
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
NCT02652715
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, +76 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Active, Not Recruiting
Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis
NCT04742387
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Bone Diseases, +39 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Active, Not Recruiting
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
NCT03038672
- Conditions
- ALK-Positive Large B-Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +53 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Moffitt Cancer Center-International Plaza Tampa, Florida, United States
Active, Not Recruiting
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
NCT02911142
- Conditions
- B-Cell Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States